acetovanillone has been researched along with edaravone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hino, S; Kito, A; Matsuda, T; Morita, T; Nadano, D; Okajima, T; Oshima, K; Sugino, R; Uchida, K; Yokoshima, R | 1 |
Abd El-Ghafar, OAM; Ahmed, MA; Ajarem, JS; Allam, AA; Gad-Elrab, WM; Hassanein, EHM; Mahmoud, AM; Sayed, AM | 1 |
2 other study(ies) available for acetovanillone and edaravone
Article | Year |
---|---|
Discharge of solubilized and Dectin-1-reactive β-glucan from macrophage cells phagocytizing insoluble β-glucan particles: involvement of reactive oxygen species (ROS)-driven degradation.
Topics: Acetophenones; Acetylcysteine; Animals; Antipyrine; beta-Glucans; Cell Line; Edaravone; Enzyme-Linked Immunosorbent Assay; Humans; Lectins, C-Type; Macrophages, Peritoneal; Mice; Phagocytosis; Reactive Oxygen Species; Solubility | 2012 |
Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats.
Topics: Acetophenones; Administration, Oral; Animals; Antioxidants; Cyclophosphamide; Edaravone; Male; Molecular Docking Simulation; Myocardial Reperfusion Injury; NF-E2-Related Factor 2; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation | 2020 |